Sling Eases Male SUI After Surgery
Retrourethral transobturator sling associated with a treatment success rate of 77.1% at one year.
Retrourethral transobturator sling associated with a treatment success rate of 77.1% at one year.
New findings make a case for renal disease screening of family members who have risk factors.
Transcatheter polycystic embolization was well-tolerated, and no deaths occurred as a result.
A recent study shows that sodium bicarbonate is no better than saline in preventing contrast-induced nephropathy (CIN).
The association is especially strong among men younger than 65 years, according to researchers.
Radiofrequency ablation of small renal tumors in otherwise healthy patients preserves renal function.
Endo Pharmaceuticals, of Chadds Ford, Pa., has reintroduced Valstar (valrubicin) for the treatment of carcinoma in situ (CIS) of the urinary bladder that is refractory to treatment with Bacillus-Calmette-Guérin (BCG).
Urovalve, of Newark, N.J., has filed a patent for a device that facilitates insertion of catheters, such as Foley catheters, the company said.
The FDA has approved Valcyte (valganciclovir hydrochloride) for the prevention of cytomegalovirus (CMV) disease in pediatric kidney and heart transplant recipients (aged four months to 16 years) who are at high risk of developing the disease.
Salix Pharmaceuticals has receiving marketing clearance for Metozolv (metoclopramide HCl) ODT (orally dissolving tablets) 5 mg and 10 mg orally disintegrating tablets for the relief of diabetic gastroparesis and symptomatic documented gastroesophageal reflux (GERD).